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Abstract 
The minimum information about a biofilm experiment (MIABiE) initiative has arisen from the 
need to find an adequate and scientifically sound way to control the quality of the documentation 
accompanying the public deposition of biofilm-related data, particularly those obtained using 
high-throughput devices and techniques. Thereby, the MIABiE consortium has initiated the 
identification and organization of a set of modules containing the minimum information that needs 
to be reported to guarantee the interpretability and independent verification of experimental results 
and their integration with knowledge coming from other fields. MIABiE does not intend to 
propose specific standards on how biofilms experiments should be performed, because it is 
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acknowledged that specific research questions require specific conditions which may deviate 
from any standardization. Instead, MIABiE presents guidelines about the data to be recorded and 
published in order for the procedure and results to be easily and unequivocally interpreted and 
reproduced. Overall, MIABiE opens up the discussion about a number of particular areas of 
interest and attempts to achieve a broad consensus about which biofilm data and metadata should 
be reported in scientific journals in a systematic, rigorous and understandable manner. 
 
Introduction 
One of the major goals of microbial systems biology is to obtain comprehensive knowledge not 
only of individual cells, but also of entire microbial communities (Zengler & Palsson, 2012). In 
nature, these microbial communities can mostly be found in the form of biofilms, which are 
complex, three-dimensional aggregates of microbial cells enclosed  in a self-produced polymeric 
matrix and living at interfaces (Hall-Stoodley et al., 2004). 
While for planktonic individual cells the emergence of high-throughput methods and subsequent 
‘omics’ disciplines has been fast, the evolution of technologies for scrutinizing sessile microbial 
communities has been slower. Nonetheless, similarly to what has happened in other research fields, 
the field of biofilms is starting to rely heavily on high-through- put techniques to boost the 
understanding of key phenomena related to microbial communities (Peeters et al., 2008; Azevedo, 
2012). For instance, the development and standardization of high-throughput biofilm methods 
based upon microtitre plates assays (Ceri et al., 1999; Stepanovi,c et al.,2000) has paved the way 
for the formation of similar biofilms in a large number of experiments. Some of these methods 
have even been validated by a standard setting organization (ASTM, 2012). Metagenomics, 
metaproteomics and other ‘omics’ technologies may then be applied to these structures in order to 
unveil the genome, transcriptome and proteome of the microbial community  (Schmeisser  et al.,  
2003;  Ram et al., 2005; Pepperkok & Ellenberg, 2006; Gjersing et al., 2007; Yergeau et al., 
2010). Other parameters that are crucial for a full understanding of a spatially structured 
ecosystem, such as the location of microorganisms and matrix components, may also be assessed 
in a high-through- put manner in the near future using specific microscopy methods (Pepperkok 
& Ellenberg, 2006; Azevedo, 2012). 
The study of biofilms is hence becoming a data-intensive research field that must adapt to this 
new reality by deploying and enforcing novel methodologies in terms of data management and 
analysis. As in other areas, issues such as lack of data reproducibility, scarcity of standardized 
protocols, poor data quality and incomplete data sets significantly hamper the quality of published 
results (Huang & Gottardo, 2013). In fact, with the exception of data related to more established 
techniques developed for microbial communities as a whole (such as metagenomics), a large 
volume of biofilm data from published experiments lay in the private files of researchers. Public 
release of data in novel online platforms dedicated to biofilms, such as BiofOmics (Lourenc_o et 
al., 2012), is welcome but not sufficient. The lack of specific details about the experimental 
technique(s) employed, and the corresponding experimental conditions will still limit data 
interpretability by other researchers besides the authors (Sousa et al., 2012). 
Data standardization and structuring in biofilm research is therefore crucial to allow researchers 
to understand, replicate and assess studies at an interlaboratory scale. This requires the definition 
of the minimum information that must be documented to ensure that an experiment on microbial 
biofilms is described unambiguously and comprehensively. Following this lead, this study 
presents a new standard initiative called the minimum information about a biofilm experiment 
(MIABiE), which is preparing a set of guidelines for the documentation of biofilm experiments 
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and data, namely the minimum information checklists. Although the MIABiE consortium already 
consists of experts with a wide variety of research interests in biofilms, this initiative is expected 
to serve as a starting point for a broader, interdisciplinary community discussion. This concept 
pro- vides a common platform which makes it easier to compare results obtained from different 
environments and settings. 
 
Benefits of MIABiE 
MIABiE allows researchers to summarize the purpose, methodology and principal conclusions 
of a biofilm study, with the following primary objectives: 
(1) assist authors in creating standard-compliant and structured machine-readable digital 
summaries of the data sets and other outputs related to particular biofilms studies; 
(2) assist authors in the process of writing comprehensive and unambiguous reports of their 
research, by bringing to their attention essential experimental details that should be specified in 
their papers; 
(3) facilitate the reproduction of experimental procedures, by formulating rules and guidelines 
to be met by method- ology description; 
(4) enable incremental experimental designs, by using findings from previous experiments, 
either to complement  or validate new results; 
(5) assist reviewers of journal articles in assessing the relevance of reported results; 
(6) underpin the development of specialized bioinformatics tools, both to produce the standard-
compliant and structured machine-readable digital summaries, and to comply with more 
ambitious research goals and thus achieve a coordinated understanding of microbial communities; 
(7) to statistically evaluate those experimental parameters individually and interactively that are 
most important in influencing biofilm growth, development and response, and to identify possible 
‘gaps’ which can be interrogated in silico or experimentally, allowing continual refinement of the 
model. 
It is important to highlight that MIABiE does not intend to establish specific rules or provide 
standards on how biofilm experiments should be performed. Instead, MIABiE provides guidelines 
about the data to be recorded, considering the purpose of the study and the devices and techniques 
involved, in order for the procedure and the results to be easily reproducible and interpretable. 
 
The MIABiE modules 
The major challenge encountered when providing guidelines to document biofilm experiments 
and report their results is the complexity and variability of biofilm studies. For instance, studies 
may vary in the number and kind of conditions tested, the wide range of microorganisms that can 
be studied (both at the species and strain level), the inter- and intraspecies interactions these 
organisms may establish in multispecies biofilms, the initial physical and chemical conditions, 
the biofilm experimental model system (s) used, the type and number of analytical methods 
involved, specific data preprocessing, the number of technical and biological replicates 
performed, and the statistical method(s) used to analyse the data. 
To better capture such complexity and variability in biofilm studies, the concept of module, 
already used for reporting minimum information guidelines in other fields (Taylor et al., 2007), 
was used. Each module addresses the standardized collection, integration, storage and 
dissemination of data on specific aspects of a biofilm study (e.g. antimicrobial susceptibility 
testing), biofilm-related device (e.g. the microtitre plate) or biofilm-related technique [e.g. the 
crystal violet (CV) assay]. Following an extensive discussion between members of the biofilm 
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community, a set of 15 modules is proposed here. Each module represents a particular area of 
interest that critically influences the results of a biofilm experiment (Table 1); the set of modules 
can be easily expanded if necessary. The introduction and delineation of each module was based 
on the following criteria: (1) all biofilm-related experiments should comprehensively fit into one 
or more of the modules; (2) as most biofilm studies are greatly influenced by the type of device and 
operation mode used to develop them (Buckingham-Meyer et al., 2007), biofilm model systems 
were grouped according to their characteristics and mode of operation; (3) the many unique 
parameters associated with in vivo biofilm formation or biofilm formation on biotic or abiotic 
surfaces warrant the creation of distinct modules; and (4) techniques that are common to other 
research areas should be in modules of their own, delegating their description to the minimum 
information guidelines established by the corresponding initiative. 
As shown in Fig. 1, the modular approach is quite flexible, that is, as new devices, techniques or 
applications become increasingly popular, a new module can be created and integrated in this list 
without affecting the guidelines already in use in other modules. In fact, novel research questions 
often require modifying the published protocols and methods to achieve relevant answers. It is 
important that the modifications to the published methods be clearly documented to understand 
how the method itself evolves with the research data and knowledge gained. 
A second major advantage is the delegation of responsibility, that is, the MIABiE consortium is 
focused on biofilm-specific data issues, relying on the guidelines of other consortia to link to other 
research areas. 
 
Integration of MIABiE with other minimum information  guidelines 
As already mentioned, biofilm research is built upon biofilm-specific experiments and 
experiments from other scientific areas. To address this interrelation, MIABiE has engaged 
MIBBI (http://www.mibbi.org/), an initiative that provides a common portal with minimum 
information check- lists, standards and guidelines from all areas of biological and biomedical 
sciences (Taylor et al., 2008). 
At the core of the MIABiE strategy is the delegation of the documentation guidelines of non-
biofilm-specific data. For instance, data coming from transcriptome, proteome and other ‘omic’ 
technologies applied to biofilm populations should be documented as suggested by MIAME 
(Brazma  et al., 2001), MIAPE (Taylor et al., 2007) and similar guidelines (Fig. 2a). This would 
also be the case for specific techniques, such as fluorescence in situ hybridization or flow 
cytometry, for which minimum information guidelines have also been reported (Deutsch et al., 
2008; Lee et al.,  2008). 
 
Availability of biofilm-centered databases and portals 
For many years, the main source of biofilm information has been the scientific literature. This 
is hardly an optimal solution as manual curation of scientific literature is resource- and time-
consuming (Lok, 2010; Lu & Hirschman, 2012). Far more important, biofilm-related publications 
do not usually have experimental or analytical raw data attached, which hampers attempts to 
reproduce certain experiments. 
A strong indication that this situation is about to change is the emergence of databases and other 
public websites where data on biofilm experiments are made readily available (Inst. Pasteur, 2013; 
NASA, 2013; Proteome commons, 2013). Since 2012, the BiofOmics Web database offers a 
public site for experimental data and results from biofilm   experiments   (Lourenc_o   et al.,   2012).   
BiofOmics developers have committed to a trade-off between MIABiE guidelines and the 
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donation of data, and data submitters are encouraged to comply with MIABiE guidelines, by 
creating a standardized Excel data workbook. 
Although the BiofOmics platform can be extended to accommodate more data, the idea is not 
to cover all data, especially if they are not specific to biofilm experiments (Fig. 2b). Most of the 
results generated by Module 12, for instance, will be stored in ‘omics’ databases, such as the Gene 
Expression Omnibus (GEO) database (Edgar et al., 2002) and the PRoteomics IDEntifications 
(PRIDE) data- base (Wang et al., 2012), which keep data on the transcriptome and proteome of 
organisms, respectively. The use of these resources, rather than creating specialized ones, has two 
main advantages: it alleviates biofilm-centered data- bases of the burden of duplicating the storage 
of such large data volumes, while relying on the documentation guidelines established by ‘omics’ 
experts. 
 
Use and creation of vocabularies and terminology  standardization 
MIABiE enforces the use of controlled vocabularies that facilitate the transmission of 
information, in terms of comprehensibility and interpretation. Ambiguity as the field develops its 
own terminology can occur not only within the field but also between different fields. For 
example, the term ‘extracellular matrix’ (ECM) has been used in plant and animal biology to refer 
to extracellular materials which may have   a  structural  role   (e.g.  connective),  but  has  been 
gaining use by biofilm researchers where it has been replacing what was previously known as 
‘extracellular polysaccharides’ or more  generically, as the complexities of the biofilm matrix 
have been revealed, ‘extracellular polymeric substances’ (EPS) (Flemming & Wingender, 2010). 
The use of ‘matrix’ to discuss the biofilm EPS has caused confusion, particularly when the 
biofilm might be investigated in clinical specimens where it is not clear whether ECM refers to 
the host or microbial derived fractions. Another term which can result in ambiguity is ‘substrate’. 
In some cases, this term is used, more in the engineering community, to refer to the surface that 
biofilms are grown on, while the more common usage is as a nutrient. Regarding the data 
documenting a biofilm experiment, MIABiE has already looked into existing vocabularies. For 
instance, microorganisms and their sequences are catalogued in NCBI Taxonomy and GenBank 
(NCBI Resource Coordinators, 2013), strain numbers in international culture collections can be 
found in Straininfo.net (Dawyndt et al., 2005), and metabolism is described in pathway 
databases such as KEGG (Kanehisa et al., 2012) and BioCyc (Caspi et al., 2012). By cross-linking 
to these databases, researchers obviate the need to include this sort of data on their experiment 
files. 
Portals such as the Open Biological and Biomedical Ontologies (OBO) foundry 
(http://www.obofoundry.org/) congregate a number of biological vocabularies potentially useful 
in biofilm descriptions (Ceusters & Smith, 2010). For instance, the PATO ontology (Beck et al., 
2009), which describes phenotypic qualities generically, could be adapted or extended to include 
qualities specific of microbial com- munities. Likewise, systems biology approaches could benefit 
greatly from the efforts of Gene Ontology Consortium to annotate various biofilm aspects (Gene 
Ontology Consortium, 2013). Moreover, dictionaries on nonspecific information could be derived 
from databases and associated terminologies. For example, antimicrobial products, such as drugs 
and natural peptides, are being catalogued in Drug- Bank (Knox et al., 2011) and the Collection 
of Anti-Microbial Peptides (CAMP) (Thomas et al., 2010), respectively. 
Vocabularies on biofilm specifics such as devices, techniques, materials and media are not 
available. Similarly, the qualitative description of biofilm features and behaviour, namely the 
morphology of the colonies when facing particular stresses, was subjective. Given their critical 
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role in the description of the experiment, MIABiE initiated the elaboration of vocabularies 
covering these aspects, once again reaching out to the community for a consensus. 
 
Final remarks 
Similarly to what happened in other fields of Biology, the study of biofilms has entered the high-
throughput era. Because data and knowledge accumulate rapidly, it is crucial to empower 
researchers with instant access to this information. New studies could be justified, integrated or 
contextualized by previous knowledge by comparing results from multiple, expected to be similar, 
experiments. Thereby, it seems only logical that to pursue high-quality research, biofilm experts 
engage into systematic data management and interchange. 
Consequently, MIABiE proposes a standards initiative that intends to simplify the exchanging 
and comparison of biofilm data across different laboratories, by ensuring that authors document 
their experiments comprehensively and unequivocally in scientific publications. MIABiE also 
aims at complementing existing minimum information guidelines for other high-throughput 
fields, to assist in the completeness of data provided for a study. For instance, if an experiment on 
proteomics is carried out on biofilms, the data on proteomics might become less meaningful if the 
characterization of the microbiological sample is not complete. By providing adequate 
background to the microbiological sample, MIABiE ensures that results from such experiments 
can be better interpreted in the future. 
Finally, MIABiE attempts to decrease the variability of results obtained from biofilm studies. 
Over time, this variability has become accepted as some sort of inevitability. While it is unlikely 
that this initiative will reduce variability to the level observed for individual cells, it will allow 
source discrimination into experimental variations, and intrinsic and extrinsic noise due to the 
microorganisms (Elowitz et al., 2002). This ability is important to assess the disparity of results 
obtained by different laboratories applying biofilm-related technologies under similar conditions, 
as well as to perform head-to-head comparisons between some of the most commonly used 
technologies, for example CV and XTT. 
The success of MIABiE initiative depends on establishing a consensus within the biofilm 
community. At the moment, MIABiE modules and reporting requirements are being identified by 
the MIABiE consortium, but a broader community discussion should be pursued continuously. 
This discussion will be conducted either through e-mail discussion lists (details on the website, 
http://www.miabie.org) or on speciality conferences on biofilms. The first of these conference 
discussions was held at the Eurobiofilms 2013 meeting in Ghent, Belgium (9–12 September 
2013). 
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Fig.  1  Schematic representation of the modules proposed by MIABiE. 
 
 
 
 
Fig. 2 A schematic diagram, showing the relation between the different modules, MIBBIs and 
online resources; (a) the different sets of minimum information guidelines available; and (b) the 
databases where parameters and data can be accommodated. This scheme should not be interpreted 
as a fixed scheme, but rather as a starting point that will be adjusted as biofilm studies, databases 
and minimum information guidelines become integrated and evolve in time. 
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Table 1  Description of the modules proposed by  MIABiE 
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